Results 211 to 220 of about 13,617 (225)

Omalizumab

Reactions Weekly, 2022
openaire   +2 more sources

Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy

Allergy and Asthma Proceedings, 2007
Robert G Hamilton, Hamilton Robert G
exaly  

Omalizumab

Reactions Weekly, 2009
openaire   +1 more source

Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma

Allergy: European Journal of Allergy and Clinical Immunology, 2011
Marc Humbert, Klaus F Rabe
exaly  

Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils☆

Journal of Allergy and Clinical Immunology, 2004
Calman Prussin, Barbara Foster, F A Romero   +2 more
exaly  

Systematic review on the use of omalizumab for the treatment of asthmatic children and adolescents

Pediatric Allergy and Immunology, 2015
Gustavo J Rodrigo, Hugo Neffen
exaly  

Omalizumab

Reactions Weekly, 2008
openaire   +1 more source

Effectiveness of omalizumab (Xolair®) in the first patients treated in real-life practice in France

Respiratory Medicine, 2008
Mathieu Molimard, Frédéric De Blay, Alain Didier   +2 more
exaly  

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

Journal of Allergy and Clinical Immunology, 2001
William W Busse, Jonathan Corren, Niroo Gupta   +2 more
exaly  

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study

Journal of Allergy and Clinical Immunology: in Practice, 2019
Thomas B Casalé, William W Busse, Robert S Zeiger   +2 more
exaly